- Home
- ACEL vs CMPX Comparison
ACEL vs CMPX Comparison
Compare ACEL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | CMPX |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.7M | 926.7M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACEL | CMPX |
|---|---|---|
| Price | $10.93 | $5.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $14.00 | ★ $14.43 |
| AVG Volume (30 Days) | 280.1K | ★ 1.8M |
| Earning Date | 01-01-0001 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | N/A | ★ $850,000.00 |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $4.29 | N/A |
| P/E Ratio | $26.73 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.02 | $1.33 |
| 52 Week High | $12.92 | $6.88 |
Technical Indicators
Market Signals| Indicator | ACEL | CMPX |
|---|---|---|
| Relative Strength Index (RSI) | 41.45 | 43.57 |
| Support Level | $10.13 | $4.78 |
| Resistance Level | $11.63 | $5.86 |
| Average True Range (ATR) | 0.28 | 0.32 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 16.35 | 7.94 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.